Verstraete Stephany 4
4 · Teladoc Health, Inc. · Filed Sep 4, 2024
Insider Transaction Report
Form 4
Verstraete Stephany
Chief Marketing Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-08-30−3,255→ 19,532 total→ Common Stock (3,255 underlying) - Exercise/Conversion
Performance Stock Units
2024-08-30−1,109→ 6,658 total→ Common Stock (1,109 underlying) - Exercise/Conversion
Common Stock
2024-08-30+1,109→ 46,267 total - Exercise/Conversion
Common Stock
2024-08-30+1,404→ 47,671 total - Exercise/Conversion
Common Stock
2024-08-30+3,255→ 50,926 total - Sale
Common Stock
2024-09-03$7.16/sh−2,083$14,923→ 48,843 total - Exercise/Conversion
Restricted Stock Units
2024-08-30−1,404→ 2,808 total→ Common Stock (1,404 underlying)
Footnotes (6)
- [F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F2]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
- [F4]The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F5]On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F6]On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.